| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 798 | 793 | 836 | 1,012 | | Cost of Revenue | 456 | 463 | 493 | 1,497 | | | Gross Profit | 342 | 330 | 343 | (484) | | | Operating Expenses | | Research Development | 92 | 92 | 74 | 149 | | Selling General and Administrative | 1,932 | 2,018 | 2,433 | 2,375 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,681) | (1,780) | (2,165) | (3,009) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 2 | 12 | 46 | | Earnings Before Interest And Taxes | (1,680) | (1,778) | (2,153) | (2,963) | | Interest Expense | 2 | 2 | 2 | 18 | | Income Before Tax | (1,681) | (1,779) | (2,155) | (2,981) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,681) | (1,779) | (2,155) | (2,981) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,681) | (1,779) | (2,155) | (2,981) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,681) | ($1,779) | ($2,155) | ($2,981) |
|
0.31% Nasdaq 
0.05%
Income Statement
